share_log
Reuters ·  01/07 16:19

Maze Therapeutics - Entities Affiliated With Third Rock Ventures Beneficially Owned 20.1% of Common Shares Prior to Offering

Maze Therapeutics - 与第三岩风险投资相关的实体在公开发行之前拥有20.1%的普通股

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发